Singh M - Search Results

1

A common Matrix metalloproteinase 8 promoter haplotype enhances the risk for hypertension via diminished interactions with nuclear factor kappa B.

Maghajothi S, Subramanian L, Mani P, Singh M, Iyer DR, Sharma S, Khullar M, Victor SM, Asthana S, Mullasari AS, Mahapatra NR. Maghajothi S, et al. Among authors: singh m. J Hypertens. 2022 Nov 1;40(11):2147-2160. doi: 10.1097/HJH.0000000000003234. Epub 2022 Jul 22. J Hypertens. 2022. PMID: 36040233

2

Computational modeling suggests impaired interactions between NKX2.5 and GATA4 in individuals carrying a novel pathogenic D16N NKX2.5 mutation.

Mattapally S, Singh M, Murthy KS, Asthana S, Banerjee SK. Mattapally S, et al. Among authors: singh m. Oncotarget. 2018 Feb 9;9(17):13713-13732. doi: 10.18632/oncotarget.24459. eCollection 2018 Mar 2. Oncotarget. 2018. PMID: 29568389 Free PMC article.

3

Molecular dynamics simulation reveals the possible druggable hot-spots of USP7.

Srivastava M, Suri C, Singh M, Mathur R, Asthana S. Srivastava M, et al. Among authors: singh m. Oncotarget. 2018 Sep 28;9(76):34289-34305. doi: 10.18632/oncotarget.26136. eCollection 2018 Sep 28. Oncotarget. 2018. PMID: 30344943 Free PMC article.

4

A Common Tag Nucleotide Variant in MMP7 Promoter Increases Risk for Hypertension via Enhanced Interactions With CREB (Cyclic AMP Response Element-Binding Protein) Transcription Factor.

Subramanian L, Maghajothi S, Singh M, Kesh K, Kalyani A, Sharma S, Khullar M, Victor SM, Swarnakar S, Asthana S, Mullasari AS, Mahapatra NR. Subramanian L, et al. Among authors: singh m. Hypertension. 2019 Dec;74(6):1448-1459. doi: 10.1161/HYPERTENSIONAHA.119.12960. Epub 2019 Oct 28. Hypertension. 2019. PMID: 31656093

5

Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach.

Mittal L, Kumari A, Srivastava M, Singh M, Asthana S. Mittal L, et al. Among authors: singh m. J Biomol Struct Dyn. 2021 Jul;39(10):3662-3680. doi: 10.1080/07391102.2020.1768151. Epub 2020 May 20. J Biomol Struct Dyn. 2021. PMID: 32396769 Free PMC article.

6

Elucidation of Structural Determinants Delineates the Residues Playing Key Roles in Differential Dynamics and Selective Inhibition of Sirt1-3.

Singh M, Srivastava M, Wakode SR, Asthana S. Singh M, et al. J Chem Inf Model. 2021 Mar 22;61(3):1105-1124. doi: 10.1021/acs.jcim.0c01193. Epub 2021 Feb 19. J Chem Inf Model. 2021. PMID: 33606530

7

Structure-based pharmacophore mapping and virtual screening of natural products to identify polypharmacological inhibitor against c-MET/EGFR/VEGFR-2.

Varma DA, Singh M, Wakode S, Dinesh NE, Vinaik S, Asthana S, Tiwari M. Varma DA, et al. Among authors: singh m. J Biomol Struct Dyn. 2023 Apr;41(7):2956-2970. doi: 10.1080/07391102.2022.2042388. Epub 2022 Feb 23. J Biomol Struct Dyn. 2023. PMID: 35196966

8

Design and synthesis of amino acid derivatives of substituted benzimidazoles and pyrazoles as Sirt1 inhibitors.

Purushotham N, Singh M, Paramesha B, Kumar V, Wakode S, Banerjee SK, Poojary B, Asthana S. Purushotham N, et al. Among authors: singh m. RSC Adv. 2022 Jan 30;12(7):3809-3827. doi: 10.1039/d1ra06149f. eCollection 2022 Jan 28. RSC Adv. 2022. PMID: 35425455 Free PMC article.

9

Characterizing (un)binding mechanism of USP7 inhibitors to unravel the cause of enhanced binding potencies at allosteric checkpoint.

Srivastava M, Mittal L, Kumari A, Agrahari AK, Singh M, Mathur R, Asthana S. Srivastava M, et al. Among authors: singh m. Protein Sci. 2022 Sep;31(9):e4398. doi: 10.1002/pro.4398. Protein Sci. 2022. PMID: 36629250 Free PMC article.

10

[No title available]

[No authors listed] [No authors listed] PMID: 36783221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,723 results

Search Page